Literature DB >> 9352654

Bis-tropolonato derivatives of cobalt(III) complexes of bidentate aliphatic nitrogen mustards as potential hypoxia-selective cytotoxins.

D C Ware1, H R Palmer, P J Brothers, C E Rickard, W R Wilson, W A Denny.   

Abstract

A series of cobalt(III) complexes, [Co(trop)2(L)]+, where trop is the tropolonate anion and L is a bidentate amine or nitrogen mustard, have been prepared as potential hypoxia-selective cytotoxins (L = BEE, N,N'-diethylethylenediamine; DEE, N,N-diethylethylenediamine; BCE, N,N'-bis(2-chloroethyl)ethylenediamine; DCE, N,N-bis(2-chloroethyl)ethylenediamine). The 1H NMR and 13C{1H} NMR spectra of the complexes were assigned on the basis of chemical shift considerations, 2D NMR studies (including 13C-1H and 1H-1H COSY correlation experiments), and comparison to the related, known acetylacetonato (acac) complexes [Co(acac)2(L)]+. An x-ray crystal structure determination of the analogue [Co(trop)2(BEE)]ClO4 showed it to be the delta SS/lambda RR enantiomeric pair of diastereomers. The tropolonato complexes have significantly higher reduction potentials than the corresponding acac complexes, suggesting more facile cellular reduction. In agreement with this, the mustard complexes have IC50 values in cells little different to those of the free mustards even under aerobic conditions, and do not show hypoxic selectivity in a clonogenic assay under conditions where the corresponding 3-methylacac complex of DCE showed significant selectivity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9352654     DOI: 10.1016/s0162-0134(97)00090-1

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  6 in total

Review 1.  Redox activation of metal-based prodrugs as a strategy for drug delivery.

Authors:  Nora Graf; Stephen J Lippard
Journal:  Adv Drug Deliv Rev       Date:  2012-01-25       Impact factor: 15.470

Review 2.  Cobalt derivatives as promising therapeutic agents.

Authors:  Marie C Heffern; Natsuho Yamamoto; Robert J Holbrook; Amanda L Eckermann; Thomas J Meade
Journal:  Curr Opin Chem Biol       Date:  2012-12-24       Impact factor: 8.822

3.  Synthesis, characterization, and antibacterial and anticancer screening of {M(2+)-Co (3+)-M (2+)} and {Co (3+)-M (2+)} (M is Zn, Cd, Hg) heterometallic complexes.

Authors:  Nagendra K Kaushik; Anurag Mishra; Afsar Ali; J S Adhikari; Akhilesh K Verma; Rajeev Gupta
Journal:  J Biol Inorg Chem       Date:  2012-09-23       Impact factor: 3.358

Review 4.  Anticancer activity of metal complexes: involvement of redox processes.

Authors:  Ute Jungwirth; Christian R Kowol; Bernhard K Keppler; Christian G Hartinger; Walter Berger; Petra Heffeter
Journal:  Antioxid Redox Signal       Date:  2011-05-11       Impact factor: 8.401

5.  A kinetic study and mechanisms of reduction of N, N'-phenylenebis(salicyalideneiminato)cobalt(III) by L-ascorbic acid in DMSO-water medium.

Authors:  S Abdulsalam; S O Idris; G A Shallangwa; A D Onu
Journal:  Heliyon       Date:  2020-09-01

6.  Development of a cobalt(iii)-based ponatinib prodrug system.

Authors:  Marlene Mathuber; Michael Gutmann; Mery La Franca; Petra Vician; Anna Laemmerer; Patrick Moser; Bernhard K Keppler; Walter Berger; Christian R Kowol
Journal:  Inorg Chem Front       Date:  2021-03-30       Impact factor: 6.569

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.